Answer:
I'm going to assume cardiovascular disease
My personal experience has been okay! Sometimes that can change due to my different situations that involve having to communicate with the healthcare system/staff. The healthcare system tries their hardest but some don’t. Some doctors just guess your diagnosis just to get you out of the hospital, mainly to get paid. Some do wrong diagnosis due to them being tired or careless, with good research it can be proven. My negative experience was terrible. Technically, it wasn’t “MY” experience it was a family members but I was there as a witness. My aunt went in because she was sick and she had pain near her appendix. The doctor said nothing was wrong with her appendix and that she may just have a bug. Scans, test, everything was done turned out the doctor sent my aunt home with “flu” meds. Took my aunt throwing up all of her body weight to go back to another hospital because we all knew something was wrong. She went to another hospital and turns out her appendix burst and she nearly could’ve died. Therefore, the healthcare system is great and all but some doctors or healthcare workers can be very careless.
(THIS IS NOT A TRUE STORY NO SYMPATHY NEEDED HERE LOL)
Background- In patients with intracranial artery stenosis, a long-term advantage of dual antiplatelet therapy (DAPT) over single antiplatelet therapy (SAPT) for the prevention of recurrent stroke has not been proven. We studied patients with intracranial arterial stenosis who were enrolled in the Cilostazol Stroke Prevention Study for Antiplatelet Combination trial, a randomized controlled trial in high-risk Japanese patients with ischemic stroke, to compare the efficacy and safety of DAPT with cilostazol and clopidogrel or aspirin to those of SAPT with clopidogrel or aspirin. Techniques and Outcomes In patients with ischemic stroke with symptomatic or asymptomatic intracranial arterial stenosis of at least 50% in a major intracranial artery, we compared the vascular and hemorrhagic events between DAPT and SAPT.
Patients were divided into two groups: 275 were given DAPT, while 272 were given SAPT. In contrast to SAPT, which had a higher risk of serious or life-threatening bleeding, DAPT had a lower risk of ischemic stroke (hazard ratio [HR], 0.47; 95% CI, 0.23-0.95); and a composite of stroke, myocardial infarction, and vascular mortality (HR, 0.48; 95% CI, 0.26-0.91). Conclusions In patients with intracranial artery stenosis following stroke, DAPT using cilostazol was superior than SAPT using clopidogrel or aspirin for the prevention of recurrent stroke and vascular events without raising bleeding risk.
<h3>What is
stroke?</h3>
When anything prevents blood flow to a portion of the brain or when a blood artery in the brain bursts, a stroke, also known as a brain attack, happens. The brain either ages or suffers harm in both scenarios. A stroke may result in permanent brain damage, chronic disability, or even fatality.
To learn more about stroke with the help of given link:
brainly.com/question/26482925
#SPJ4
Answer:
the total volume divided by time mutiplied by the drop factor = flow rate
Explanation:
